CS247190B2 - Method of agent with porous matrix production on polycaprolactam base - Google Patents

Method of agent with porous matrix production on polycaprolactam base Download PDF

Info

Publication number
CS247190B2
CS247190B2 CS8510A CS1085A CS247190B2 CS 247190 B2 CS247190 B2 CS 247190B2 CS 8510 A CS8510 A CS 8510A CS 1085 A CS1085 A CS 1085A CS 247190 B2 CS247190 B2 CS 247190B2
Authority
CS
Czechoslovakia
Prior art keywords
weight
tablets
polycaprolactone
total
heat treatment
Prior art date
Application number
CS8510A
Other languages
Czech (cs)
English (en)
Inventor
Herve Grouiller
Fabien Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of CS247190B2 publication Critical patent/CS247190B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
CS8510A 1984-01-02 1985-01-02 Method of agent with porous matrix production on polycaprolactam base CS247190B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (1)

Publication Number Publication Date
CS247190B2 true CS247190B2 (en) 1986-12-18

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
CS8510A CS247190B2 (en) 1984-01-02 1985-01-02 Method of agent with porous matrix production on polycaprolactam base

Country Status (23)

Country Link
US (1) US4629624A (da)
EP (1) EP0147335B1 (da)
JP (1) JPS60185729A (da)
KR (1) KR850005271A (da)
AT (1) ATE33553T1 (da)
AU (1) AU574024B2 (da)
CA (1) CA1238856A (da)
CS (1) CS247190B2 (da)
DD (1) DD235829A5 (da)
DE (1) DE3470459D1 (da)
DK (1) DK616084A (da)
ES (1) ES8605682A1 (da)
FI (1) FI79942C (da)
FR (1) FR2557459B1 (da)
GR (1) GR82607B (da)
HU (1) HU193731B (da)
IL (1) IL73957A (da)
NO (1) NO160412C (da)
OA (1) OA08018A (da)
PH (1) PH22167A (da)
PT (1) PT79786B (da)
YU (1) YU223884A (da)
ZA (1) ZA857B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
CA2540984C (en) * 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
EP1680086A2 (en) * 2003-10-10 2006-07-19 LifeCycle Pharma A/S A solid dosage form comprising a fibrate and a statin
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
CN102159193B (zh) * 2008-09-18 2015-09-16 普渡制药公司 包含聚(ε-己内酯)的药物剂型
US20150265536A1 (en) * 2011-12-09 2015-09-24 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (da) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
IL73957A0 (en) 1985-03-31
EP0147335A2 (fr) 1985-07-03
FR2557459B1 (fr) 1986-05-30
PT79786B (fr) 1986-10-28
PH22167A (en) 1988-06-28
JPS60185729A (ja) 1985-09-21
US4629624A (en) 1986-12-16
IL73957A (en) 1988-02-29
DE3470459D1 (en) 1988-05-26
ATE33553T1 (de) 1988-05-15
AU3720984A (en) 1985-07-11
HUT37567A (en) 1986-01-23
PT79786A (fr) 1985-02-01
FI845088L (fi) 1985-07-03
ZA857B (en) 1985-08-28
FR2557459A1 (fr) 1985-07-05
AU574024B2 (en) 1988-06-23
GR82607B (en) 1985-02-11
ES8605682A1 (es) 1986-04-01
OA08018A (fr) 1987-01-31
DK616084A (da) 1985-07-03
CA1238856A (en) 1988-07-05
EP0147335A3 (en) 1985-07-31
DD235829A5 (de) 1986-05-21
FI79942C (fi) 1990-04-10
NO160412C (no) 1989-04-19
FI79942B (fi) 1989-12-29
DK616084D0 (da) 1984-12-20
EP0147335B1 (fr) 1988-04-20
ES539187A0 (es) 1986-04-01
FI845088A0 (fi) 1984-12-21
YU223884A (en) 1987-10-31
NO845273L (no) 1985-07-03
HU193731B (en) 1987-11-30
KR850005271A (ko) 1985-08-24
NO160412B (no) 1989-01-09

Similar Documents

Publication Publication Date Title
EP0218148B1 (en) Slow-release pharmaceutical composition
CS247190B2 (en) Method of agent with porous matrix production on polycaprolactam base
FI82187B (fi) Foerfarande foer framstaellning av lagerstabila snabbsoenderfallande farmaceutiska aktivaemnespresstycken.
US5211958A (en) Pharmaceutical composition and process for its preparation
JP3010562B2 (ja) 徐放性調剤単位
KR960005141B1 (ko) 서방성 제제
JPS61501151A (ja) 拡散被覆された複合単位服用剤
US20010012518A1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
EP0797435A1 (en) Controlled release matrix for pharmaceuticals
CA2182004C (en) Film coated tablet of paracetamol and domperidone
KR20100020480A (ko) Ｄｐｐ-ｉｖ 저해제를 위한 안정한 약제학적 제제
JP2001523719A (ja) チアガビンを含有するスフェロイド、製造方法および医薬組成物
KR100315618B1 (ko) 베타-페닐프로피오페논유도체의지연방출성미세정제
JPH03500288A (ja) 徐放性ニフェジピン製剤
US4863741A (en) Tablet composition for drug combinations
CZ280475B6 (cs) Pevné formy pro orální aplikaci, které jako účinnou látku obsahující ifosfamid
JPH06501247A (ja) 側縁コーティング制御放出医薬組成物
KR20100041780A (ko) 옥스카르바제핀을 포함하는 방출 제어형 고체 제제의 제조 방법 및 그에 의해 얻어질 수 있는 제제
EP0319074A1 (en) Pharmaceutical composition and process for its preparation
JP2638604B2 (ja) 徐放性製剤
CA1266235A (en) Tablet composition for drug combinations
JPH0130A (ja) 徐放性製剤
WO2023128898A1 (en) Pharmaceutical compositions comprising macitentan as active ingredient and other relevant excipients
RU2169561C1 (ru) Фармацевтическая композиция, содержащая аналог витамина k, и способ ее получения
KR20050010843A (ko) 활성 성분을 지속 방출시키는, 옥스카바제핀 함유약제학적 조성물